Skip Ribbon Commands
Skip to main content
:

DAA: Marilyn Hartig

Marilyn Hartig


Pennington, NJ


Marilyn Hartig is vice president of External Service and Technology of the pharmaceutical research Institute at Bristol-Myers Squibb in Pennington, New Jersey. She is responsible for negotiating and managing alliances and licenses to access technology from outside the company. Sources of this technology include pharmaceutical and biotechnology companies, research institutes, and universities. Dr. Hartig division also manages the institute’s research and development portfolio review and prioritization process, and provides competitive intelligence related to internal development projects. In short, Marilyn is a key player in a central leader at Bristol-Myers Squibb. In addition to her scientific knowledge, she is skilled at handling difficult negotiations and accomplishing mutually beneficial outcomes for the parties involved. After earning a bachelor's degree in chemistry from St. Olaf College in Northfield, Minnesota, Marilyn came to Purdue’s department of biochemistry. After completing her Ph.D., she was a postdoctoral fellow at the University of California, San Francisco. Her research efforts focus on hepatitis B virus and AIDS. She joined Bristol-Myers Squibb in 1987 as associate director of licensing, biotechnology division. Since then, she has directed that unit just and served as senior director of business development for biotechnology and specialty pharmaceutical products. Prior to her current assignment she was director of corporate development and vice president of Med-Tech ventures for Warner-Lambert Company in Morris Plains, New Jersey, but she was responsible for acquisition, divestment and investment activity. She also managed the company’s venture investment portfolio. In 1984, she returned to Bristol-Myers Squibb in her current position. The company is a diversified worldwide health and personal care company its principles businesses are pharmaceutical, consumer products, nutritionals and medical devices. Through her efforts, Dr. Hartig is shaping not only the different direction of Bristol-Myers Squibb, but of the future pharmaceutical industry. Marilyn grew up in Springfield, Oregon and Iowa City, Iowa. Her first licensing experience came in the patent trademark and copyright office at the University of California, Berkeley. She is a member of Licensing Executive Society and the Association of University Technology managers